Felippe Coaglio - Journalist Profile | Connect with top journalists
View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.
Get connected with journalists today
Felippe Coaglio
Verified
Correspondent, G1
New York
Beats
Biography
Killings By Police , Detroit Bankruptcy , Foreclosure And Eviction Crisis , Mass Incarceration , Wrongful Convictions , U.S. Wars , Third World Countries
Stuff I don't know about or care about
Content
Company Info
G1
G1 Therapeutics, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina. Founded in 2008, it focuses on developing small molecule therapies for cancer treatment. The company aims to improve patient outcomes by targeting cellular pathways involved in cancer progression. G1 Therapeutics became a subsidiary of Pharmacosmos A/S in September 2024. The company's flagship product, COSELA (trilaciclib), is an FDA-approved drug that protects bone marrow from chemotherapy damage. It is administered intravenously before chemotherapy to enhance patient safety. G1 Therapeutics also has a pipeline that includes lerociclib, a CDK4/6 inhibitor, and other investigational compounds aimed at cancer treatment. The company collaborates with organizations like GeneCentric Therapeutics and AstraZeneca to advance its research and clinical trials.
, ,
'+1 919-213-9835
Founded: 2008